Rheumatology

The American College of Rheumatology recommended that patients with rheumatic diseases who are on immunosuppressants receive a third dose of an mRNA COVID-19 vaccine. It was the top story in rheumatology last week.

Despite the ongoing setbacks presented by the COVID-19 pandemic, the Congress of Clinical Rheumatology – West will follow its East counterpart just a month later, offering a wholly new selection of “charismatic and engaging” speakers.

There were a handful of ways I became interested in rheumatology.

Collaboration between oncologists and rheumatologists is essential to curtail the increasing prevalence immune-related adverse events linked to checkpoint inhibitor therapy, according to a presenter here.

Johns Hopkins was named the best hospital for rheumatology for the fourth year in a row by the U.S. News & World Report, which recently released its Best Hospitals Survey for the 2021-2022 year.

This past spring, two studies shed light on how some of the largest clinician organizations and publishers in rheumatology, including the American College of Rheumatology and EULAR, have failed to provide adequate training materials or clear guidelines when it comes to caring for patients of color.

On May 22 to 23, I hosted the ninth biennial Biologics Therapies Summit at the Cleveland Clinic — virtually. To say the least, it was very different from past summits.

Rheumatologists are informed that — as a group — we are “happy” outside of work, but relatively “unhappy” in our practices when compared to other specialties. Personally, I am experiencing burnout reading stories about burnout.

The time warp of COVID-19 has offered yet another twist. As acute infections and the associated fatalities have finally begun to ebb in the United States, a new phase of the pandemic has emerged: the long-hauler phase.

My dad, Leonard Calabrese, DO, has emulated what it means to love what you do. He and I are longtime travel buddies and I had joined him for many American College of Rheumatology and EULAR conferences, attending more of these events — albeit not as a registered attendee — than most rheumatologists by the time I was in college.